Sep 17–20, 2023 | Atlanta Marriott Marquis, Atlanta, GA, United States
Scientific Organizers:
Bali Pulendran, Robert A. Seder, and Gagandeep Kang

-
Scientific Organizers: Bali Pulendran, Robert A. Seder, and Gagandeep Kang
Bali Pulendran
Robert A. Seder
Gagandeep Kang
***Meeting program subject to change.
Available Formats: = Livestream = In Person = On DemandBooking Function
Fundraising
Sunday, September 17, 2023
Session Chair
Vaccine Equity and the Future of Global Health
Session Chair
Session Chair
COVID-19 Vaccine Technologies Bolstering the Development of Neglected Tropical Disease Vaccines
Correlates of Protection for COVID-19 Vaccines
Clinical Development of an Intranasal Pneumonia Vaccine that Targets Th17 TRM Cells
Short Talk: Short Talk: A Trivalent RBD-nanoparticle Vaccine Elicits Protective Immunity against Three Human-pathogenic Coronavirus Species in Mice
Monday, September 18, 2023
Session Chair
Session Chair
Mucosal Boosting Enhances Vaccine Protection Against SARS-CoV-2 in Rhesus Macaques
A Self-adjuvated Vaccine Induces Multiple Pathways of Innate Immunity Protecting Mice against Tuberculosis
Prior SARS-CoV-2 Infection Modulates the Early Inflammatory Response to mRNA Vaccination
Evolution of Antibody Immunity to Subunit COVID-19 Vaccines
Intestinal Helminth Infection Impairs Vaccine-induced T Cell Responses and Protection against a SARS-CoV-2 Omicron Variant in Mice
Genetic Immunization with Self-Assembling SARS-CoV-2 Spike-HBsAg Nanoparticles
Session Chair
Towards a Vaccine Against Animal Sarbecoviruses and SARS-CoV2 Variants that would not need Updating
Strategy for the Development of Pancoronavirus Vaccines: Immunogen Designs and Protective Immune Responses
Short Talk: Short Talk: Ending Transmission: Multi-antigen Intranasal Vaccines Protect against Challenge by Diverse Sarbecoviruses
A Nanoparticle based Pan Coronavirus and Influenza Vaccines
Session Chair
Session Chair
Breakthrough Infection Enhances Sars-Cov-2-Specific T Cell Responses and Generates Novel Epitope Specificities
T Cell Quality in Memory and Protection
Durable Vaccine Immunity in Human Tissues
T Cell based COVID Protection Before and after the Pandemic
Pre-Existing Memory in Vaccine Responses
Tuesday, September 19, 2023
Scientific Director
Associate Dean & Professor
Assistant Professor & Physician
Session Chair
Age Related Differences in Kinetics and Magnitude of SARS-CoV-2 and Endemic Human Coronavirus Reactive Antibody Responses After Vaccination and Infection
T Cell Immune Response Induced by Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Down Syndrome
A Strategic Model and Industry Collaboration for Sustainable Development of Vaccines against Neglected Diseases
Combating the Loss in Childhood Immunization Gains in Rural Communities and Vaccination of Disabled Persons due to Covid-19: The Approach of Building Relationships and Harnessing Power in the Community
Humoral Immune Response Elicited by Mix-and-Match SARS-CoV-2 Vaccination Strategies in India
Session Chair
Session Chair
Durability of Immune Responses to Vaccination and Infection
Immune Memory to Infection and COVID-19 Vaccination
Short Talk: Computationally Designed mRNA-launched Nanoparticle Vaccines
Short Talk: Short Talk: Broadening T Cell Help by Antigen Crosslinking as a Universal Vaccine Platform against Rapidly Evolving Pathogenic Viruses
Short Talk: Short Talk: Structural Evaluation of Serum Polyclonal Antibody Responses to mRNA-1273 and NVX-CoV2373 Vaccines
Session Chair
Session Chair
Innate Immune Predictors and Mechanisms of Vaccination
Structural and Functional Determinants of Antibody Responses to Vaccination and Infection
Immune Responses Elicited by mRNA Vaccines Compared to Traditional Vaccine Platforms
Measuring Vaccine Immunity in a Dish
Short Talk: Short Talk: Placental Transfer and Durability of Maternal COVID-19 Vaccine-induced Antibodies in Infants through 6 Months of Age
Short Talk: Short Talk: Hepatitis C Virus Vaccine Immunogenicity in People who Inject Drugs: Investigating the Impact of Opioids on Dysregulated Neutrophil and T Cell Function
Wednesday, September 20, 2023
Session Chair
Session Chair
Pan-vaccine Analysis Reveals Innate Immune Endotypes Predictive of Antibody Responses to Vaccination
Transcriptional Atlas of the Human Immune Response to 13 Vaccines
Distinct Interferon-related Innate Immune Signatures in the Nasopharynx of COVID-19 Patients Depending on Disease Severity or Vaccine History
Adjuvant AS01 Activates Subcapsular Sinus Macrophages and Dendritic Cells in Human Lymph Node Explants
Human in vitro Modeling Characterizes Mechanism of Action of Adjuvantation Systems Defining Scalable and Affordable Precision Vaccine Formulations for Early Childhood
Evaluation of COVID-19 Vaccination Protocols in an Agent-based Immune Simulation Platform
Session Chair
Enhancing Vaccine Equity Before and After COVID-19
Preparing for the Next Pandemic
The CEPI Portfolio and Ecosystem Supports Development of Coronavirus Vaccines
Thursday, September 21, 2023
Merchandise Options
Registration Options
Subscribe for Updates